Overcoming the Limits of "Blind Procedures"

Securing Both Safety and Accuracy in Chest Tube Insertion

The team led by Professor Seunggeun Yoon from the Department of Cardiovascular and Thoracic Surgery at Seoul St. Mary’s Hospital, Catholic University of Korea, announced on March 25 that they have developed a next-generation medical technology—'Scope-Guided Closed Thoracostomy Drainage (SG-CTD)'—which applies an image-guided approach to overcome the limitations of conventional blind chest tube insertion procedures. The team has completed the patent registration for the associated device.

Professor Seungkeun Yoon, Department of Cardiovascular and Thoracic Surgery, Catholic University Seoul St. Mary's Hospital. Seoul St. Mary's Hospital

Professor Seungkeun Yoon, Department of Cardiovascular and Thoracic Surgery, Catholic University Seoul St. Mary's Hospital. Seoul St. Mary's Hospital

View original image

Traditional closed thoracostomy drainage is performed blindly, without allowing medical staff to visually confirm the inside of the chest cavity. This can lead to the chest tube being placed in an incorrect position or, in some cases, result in organ damage during the procedure. Statistically, there have been frequent reports of the tube not being accurately positioned, requiring additional procedures. This issue has been pointed out as a direct cause of increased medical costs and greater physical burden for patients.


The thoracoscopic chest tube insertion device developed by the research team is centered around an image-guided system that can be linked with portable imaging equipment, including smartphones. By allowing clinicians to monitor real-time images of the thoracic cavity during the procedure, the device helps prevent vascular or organ injury and enables optimal placement of the chest tube. This is regarded as an innovative approach that aligns with the current trend in the medical field toward image-based procedures.


Therefore, this technological advancement is especially significant in that it reduces the risk of complications associated with conventional procedures and enhances procedural accuracy, thereby improving patient safety.


To validate the feasibility of this technology, the team produced a demonstration device (Demo-scope) and conducted wet-lab tests using animal models. The results showed that using the image-guided system improved procedural precision compared to the traditional method, and enabled immediate primary diagnosis of internal conditions during tube insertion.


This achievement began with an award in the 'Mustard Seed Growth Center' competition, co-hosted by Seoul St. Mary’s Hospital and the Catholic Educational Foundation. The idea was further developed through several stages, culminating in patent registration after approximately four years of continuous research and refinement. During this process, Professor Heekyung Kim from the Department of Cardiovascular and Thoracic Surgery at Eunpyeong St. Mary’s Hospital, Catholic University of Korea, and specialist Gayoung Yoo from the Department of Cardiovascular and Thoracic Surgery at Asan Medical Center, also joined the research team, contributing their multi-institutional clinical expertise. The team plans to further enhance the technology through additional validation using cadavers, and aims to introduce it to medical settings both in Korea and abroad after obtaining regulatory approvals from authorities such as the Ministry of Food and Drug Safety and the Health Insurance Review & Assessment Service.


Professor Seunggeun Yoon, who led the project, stated, "Any clinician with experience in chest tube insertion has long recognized the need for real-time imaging. The image-guided device we have developed secures both safety and accuracy in the procedure, which we expect will provide patients with a safer, complication-free experience and offer clinicians a more intuitive and convenient procedural environment."



The research team is currently pursuing international patent applications and, after receiving official approvals, plans to accelerate technical support and distribution to facilitate widespread adoption of the device in clinical practice.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing